OptimizeRx Corp
OPRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$120.28M
Close$
$6.32
3.2% downside
Current Fair Value
3.2% downsideOvervalued by 3.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $120.28 Million |
|---|---|
| Enterprise Value | $124.50 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.28 |
| Beta | 1.08 |
| Outstanding Shares | 18,761,622 |
Return
| Return on Equity | 5.27% |
|---|---|
| Return on Assets | 4.09% |
| Return on Invested Capital | 2.80% |
Valuation & Multiples
| P/E Ratio | 17.49 |
|---|---|
| PEG | -22.58 |
| Price to Sales | 1.31 |
| Price to Book Ratio | 1.09 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | 28.33 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$18.74 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$20.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 46.13% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 72.99% |
|---|---|
| Total Invested | $11,274▼ 99.99% |
| Investors Holding | 2▼ 130.00% |
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...